A 4-year cross-sectional study on the basic demography and Clopidogrel resistance profile
Keywords:
age, clopidogrel, gender, resistance, sensitivityAbstract
Background and aim: Stroke is a leading cause of death and disability worldwide. Clopidogrel is widely used to prevent recurrent strokes in acute ischemic stroke patients, but clopidogrel resistance remains a significant concern due to various factors. While extensive research has been conducted on this issue, data from East Java are limited, and many cases are overlooked by clinicians. This study aimed to address this gap.
Methods: We conducted a cross-sectional study involving 108 stroke patients aged 30–80 years who were not using proton pump inhibitors (e.g., omeprazole, esomeprazole) and had been on clopidogrel therapy for at least seven days. Clopidogrel resistance was evaluated using the VerifyNow assay.
Results: Out of 108 patients, 27 (25%) were classified as having a bleeding risk. In terms of clopidogrel sensitivity, 79 patients (73%) were sensitive, while 29 (27%) were resistant. Among resistant cases, 17 were male and 12 were female. Age significantly influenced bleeding risk (p = 0.006), but not clopidogrel sensitivity (p = 0.135). Gender had a significant impact on inhibition levels (p = 0.009), as well as on base score (p = 0.009) and PRU score (p = 0.035).
Conclusions: A notable proportion of stroke patients in East Java exhibited clopidogrel resistance, with males showing higher resistance rates. Age was a significant factor for bleeding risk, while gender influenced inhibition levels and PRU scores. Further research is needed to explore the underlying reasons for the observed gender differences in clopidogrel resistance.
References
1. Krishnan K, Nguyen TN, Appleton JP, et al. Antiplatelet resistance: A review of concepts, mechanisms, and implications for management in acute ischemic stroke and transient ischemic attack. Stroke Vasc Interv Neurol. 2023;3(3):e000576. doi:10.1161/svin.122.000576.
2. Pradhan A, Bhandari M, Vishwakarma P, Sethi R. Clopidogrel resistance and its relevance: Current concepts. J Family Med Prim Care. 2024;13(6):2187–99. doi:10.4103/jfmpc.jfmpc_1473_23.
3. Parsa-Kondelaji M, Mansouritorghabeh H. Aspirin and clopidogrel resistance: A neglected gap in stroke and cardiovascular practice in Iran: A systematic review and meta-analysis. Thromb J. 2023;21(1):79. doi:10.1186/s12959-023-00522-2. [INCOMPLETE: missing page range]
4. Hidayat R, Rasyid A, Harris S, et al. Correlation of P2Y12 genetic polymorphism as risk factor of clopidogrel resistance in Indonesian stroke patients. Vasc Health Risk Manag. 2023;19:53–61. doi:10.2147/VHRM.S386107.
5. Yi X, Lin J, Zhou Q, Wu L, Cheng W, Wang C. Clopidogrel resistance increases rate of recurrent stroke and other vascular events in Chinese population. J Stroke Cerebrovasc Dis. 2016;25(5):1222–1228. doi:10.1016/j.jstrokecerebrovasdis.2016.01.014.
6. Wu Y, Shen H, Cai B, et al. Factors associated with clopidogrel resistance and clinical outcomes in ischemic cerebrovascular disease: A retrospective study. J Stroke Cerebrovasc Dis. 2024;33(6):107684. doi:10.1016/j.jstrokecerebrovasdis.2024.107684.
7. Ranucci M, Aloisio T, Di Dedda U, et al. Gender-based differences in platelet function and platelet reactivity to P2Y12 inhibitors. PLoS One. 2019;14(11):e0225771. doi:10.1371/journal.pone.0225771.
8. Hidayat R, Nabilah RA, Rasyid A, et al. Clopidogrel resistance among ischemic stroke patients and its risk factors in Indonesia. Acta Med Acad. 2022;51(1):29–34. doi:10.5644/ama2006-124.367.
9. Pontis A, Delavenne X, Verdier MC, et al. Impact of age on in vitro metabolism of clopidogrel: A potential explanation for high on-treatment platelet reactivity in the elderly. Res Pract Thromb Haemost. 2022;7(1):100014. doi:10.1016/j.rpth.2022.100014.
10. Siller-Matula JM, Trenk D, Krahenbuhl S, Michelson AD, Delle-Karth G. Clinical implications of drug-drug interactions with P2Y12 receptor inhibitors. J Thromb Haemost. 2014;12(1):2–13. doi:10.1111/jth.12445.
11. Besin V, Yulianti T, Notopuro PB, Humardani FM. Genetic polymorphisms of ischemic stroke in Asians. Clin Chim Acta. 2023;549:117527. doi:10.1016/j.cca.2023.117527.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Valentinus Besin, Farizky Martriano Humardani, Paulus Budiono Notopuro
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
